Clinical trial
Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students
NCT07156084 is registered in ClinicalTrials.gov with Canadian Immunization Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students
- Lead sponsor
- Canadian Immunization Research Network
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- September 23, 2025
- Completion date
- February 28, 2026
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hpv vaccine